 REDWOOD CITY, Calif., Feb. 03, 2021 GLOBE NEWSWIRE -- Revolution Medicines, Inc. Nasdaq: RVMD today announced the pricing of its underwritten public offering of 5,797,101 shares of common stock at a public offering price of 45.00 per share, before underwriting discounts and commissions. All of the shares of common stock are being offered by Revolution Medicines. In addition, Revolution Medicines has granted the underwriters a 30-day option to purchase up to an additional 869,565 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Revolution Medicines, are expected to be approximately 260.9 million, excluding any exercise of the underwriters option to purchase additional shares. The offering is expected to close on February 8, 2021, subject to customary closing conditions. 